Cardiac proteasome dysfunction during cold ischemic storage and reperfusion in a murine heart transplantation model

Biochemical and Biophysical Research Communications

Volumn 365, Issue 4, 2008, Pages 882-888

  Majetschak, Matthias ^a   Patel, Mayur B ^a   Sorell, Luis T ^a   Liotta, Carlos ^a   Li, Sen ^a   Pham, Si M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cold ischemia; Heart transplantation; Hypothermic organ preservation; Proteasome; Reperfusion; Ubiquitin; Ubiquitin protein conjugates; Ubiquitylation

Indexed keywords

CHYMOTRYPSIN; EPOXOMICIN; PEPTIDASE; PROTEASOME; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; HEART DISEASE; HEART TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; REPERFUSION INJURY; UBIQUITINATION;

ANIMALS; CRYOPRESERVATION; HEART TRANSPLANTATION; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MYOCARDIUM; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOME; REPERFUSION;

MURINAE; MUS;

EID: 36849041155     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.092     Document Type: Article

References (27)

1. Jahania M.S., Sanchez J.A., Narayan P., Lasley R.D., and Mentzer Jr. R.M. Heart preservation for transplantation: principles and strategies. Ann. Thorac. Surg. 68 (1999) 1983-1987
2. Patel J., and Kobashigawa J.A. Cardiac transplantation: the alternate list and expansion of the donor pool. Curr. Opin. Cardiol. 19 (2004) 162-165
3. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
4. Baumeister W., Walz J., Zühl F., and Seemüller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92 (1998) 367-380
5. Powell S.R. The ubiquitin-proteasome system in cardiac physiology and pathology. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1-H19
6. Willis M.S., and Patterson C. Into the heart: the emerging role of the ubiquitin-proteasome system. J. Mol. Cell. Cardiol. 41 (2006) 567-579
7. Zolk O., Schenke C., and Sarikas A. The ubiquitin-proteasome system: focus on the heart. Cardiovasc. Res. 70 (2006) 410-421
8. Powell S.R., Wang P., Katzeff H., Shringarpure R., Teoh C., Khaliulin I., Das D.K., Davies K.J., and Schwalb H. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid. Redox. Signal. 7 (2005) 538-546
9. Das S., Powell S.R., Wang P., Divald A., Nesaretnam K., Tosaki A., Cordis G.A., Maulik N., and Das D.K. Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H361-H367
10. Divald A., and Powell S.R. Proteasome mediates removal of proteins oxidized during myocardial ischemia. Free Radic. Biol. Med. 40 (2006) 156-164
11. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., and Szweda L.I. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J. Biol. Chem. 276 (2001) 30057-30063
12. Luo H., Wu Y., Qi S., Wan X., Chen H., and Wu J. A proteasome inhibitor effectively prevents mouse heart allograft rejection. Transplantation 72 (2001) 196-202
13. Corry R.J., Winn H.J., and Russell P.S. Heart transplantation in congenic strains of mice. Transplant. Proc. 5 (1973) 733-735
14. Meng L., Mohan R., Kwok B.H., Elofsson M., Sin N., and Crews C.M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl. Acad. Sci. USA 96 (1999) 10403-10408
15. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
16. Majetschak M., Krehmeier U., Bardenheuer M., Denz C., Quintel M., Voggenreiter G., and Obertacke U. Extracellular ubiquitin inhibits the TNFα response to endotoxin in peripheral blood mononuclear cells and regulates endotoxin hyporesponsiveness in critical illness. Blood 101 (2003) 1882-1890
17. Patel M.B., and Majetschak M. Distribution and interrelationship of ubiquitin proteasome pathway component activities and ubiquitin pools in various porcine tissues. Physiol. Res. 56 (2007) 341-350
18. Eytan E., Armon T., Heller H., Beck S., and Hershko A. Ubiquitin C-terminal hydrolase activity associated with the 26 S protease complex. J. Biol. Chem. 268 (1993) 4668-4674
19. van Nocker S., and Vierstra R.D. Multiubiquitin chains linked through lysine 48 are abundant in vivo and are competent intermediates in the ubiquitin proteolytic pathway. J. Biol. Chem. 268 (1993) 24766-24773
20. Farout L., Mary J., Vinh J., Szweda L.I., and Friguet B. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch. Biochem. Biophys. 453 (2006) 135-142
21. Gaczynska M., Osmulski P.A., Gao Y., Post M.J., and Simons M. Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity. Biochemistry 42 (2003) 8663-8670
22. Li J., Post M., Volk R., Gao Y., Li M., Metais C., Sato K., Tsai J., Aird W., Rosenberg D., Hampton T.G., Sellke F., Carmeliet P., and Simons M. PR39, a peptide regulator of angiogenesis. Nat. Med. 6 (2000) 49-55
23. Li J., Brown L.F., Laham R.J., Volk R., and Simons M. Macrophage-dependent regulation of syndecan gene expression. Circ. Res. 81 (1997) 785-796
24. Groll M., Kim K.B., Kairies N., Huber R., and Crews C.M. Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of alpha 'beta'-epoxyketone proteasome inhibitors. J. Am. Chem. Soc. 122 (2000) 1237-1238
25. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell. Biol. 2 (2001) 195-201
26. Weekes J., Morrison K., Mullen A., Wait R., Barton P., and Dunn M.J. Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 3 (2003) 208-216
27. Kostin S., Pool L., Elsasser A., Hein S., Drexler H.C., Arnon E., Hayakawa Y., Zimmermann R., Bauer E., Klovekorn W.P., and Schaper J. Myocytes die by multiple mechanisms in failing human hearts. Circ. Res. 92 (2003) 715-724